Suchergebnisse - "Bid, Hemant Kumar"

PubPharm (70)

1

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma

enthalten in: NPJ precision oncology | 2022

von Khurshid, S. | Montes, M. | Comiskey, D. | +10

2

Splice-switching of the insulin receptor in rhabdomyosarcoma: Rescuing theIR-Bisoform for better treatment options

enthalten in: bioRxiv.org | 2021

von Khurshid, S. | Montes, M. | Comiskey, D. | +8

3

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma : Preclinical correlates

enthalten in: PloS one | 2017

von Lopez, G. | Braggio, D. | Zewdu, A. | +10

4

Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis : a potential therapeutic target

enthalten in: Oncogene | 2017

von Saini, U. | Naidu, S. | ElNaggar, A. | +11

5

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy

enthalten in: PloS one | 2017

von Xiao, H. | Bid, H. | Chen, X. | +7

6

HDAC Inhibition for the Treatment of Epithelioid Sarcoma : Novel Cross Talk Between Epigenetic Components

enthalten in: Molecular cancer research : MCR | 2016

von Lopez, G. | Song, Y. | Lam, R. | +8

7

BET bromodomain inhibitor (JQ1) and tumor angiogenesis

enthalten in: Oncoscience | 2016

von Bid, H. | Kerk, S.

8

HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components

enthalten in: Molecular cancer research | 2016

von Bid, H. | Bolshakov, S. | Song, Y. | +8

9

Re : bacillus Calmette-guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy

enthalten in: European urology | 2015

von Bid, H.

CommentOn: Eur Urol. 2014 Oct;66(4):677-88. - PMID 24674149

10

A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells

enthalten in: The Journal of biological chemistry | 2015

von Xiao, H. | Bid, H. | Jou, D. | +5

1
2
3
4
5
6
7
Nächster »
[7]